A founder's guide to choosing between equity rounds and grants/credits/debt. What each costs, what each unlocks, and how to layer both without wrecking the cap table.
6 min read·Updated May 5, 2026
Loading…
FAQ
Is non-dilutive funding always better than dilutive?▾
Not always. Non-dilutive money is "free" in cash terms but expensive in time. Grants take months to apply for and have low success rates, and cloud credits cap out at infrastructure spend. When speed-to-market matters more than ownership, a $1M seed round that closes in two weeks beats a $250K SBIR Phase I that takes six months to disburse.
How much dilution is "too much" at the seed stage?▾
A common rule of thumb is to keep founders above 50% combined ownership through Series A, and above 30% through Series B. Working backward, that means roughly 20–25% total dilution at seed (10% accelerator plus SAFEs plus option pool). Past 30% at seed and Series A gets harder, since investors model lower founder motivation in late rounds.
Can I stack non-dilutive sources without conflicts?▾
Mostly yes, but check for "exclusivity" or "anti-dilution" clauses in grant agreements. Federal SBIR grants generally allow stacking with state grants, cloud credits, and accelerator stipends. Foundation grants restricted to a specific scope can conflict if two grants both fund the same scope of work; fund different milestones with different sources.
When does revenue-based financing make more sense than a SAFE?▾
When you have predictable monthly recurring revenue and the cost of capital matters less than keeping equity. RBF usually charges a 6–12% fee on the advance, repaid as a percentage of monthly revenue. Compared to a SAFE that converts to 5–10% equity at the next round, RBF is cheaper if your company eventually exits at a high valuation, more expensive if it doesn't.
Do I have to choose one path?▾
No, and you probably shouldn't. The strongest early-stage stacks combine non-dilutive sources (cloud credits plus a grant plus maybe RBF) for runway, with a small dilutive round (accelerator plus SAFE) for network and cohort. Most successful seed-stage companies in 2025–2026 used three to five sources, not one.
Every funding decision a founder makes lives on a single axis: did you pay with cash you have to repay, or with ownership you can never get back? Dilutive funding (equity rounds, accelerators, SAFEs) costs you a permanent slice of the company in exchange for capital you don't have to repay. Non-dilutive funding (grants, cloud credits, debt, revenue-based financing) costs you cash, time, or scope, but leaves your alone. The right answer is almost always "both, in the right order."
is the drop in your ownership percentage when the company issues new shares. Sell 10% of your company in an accelerator round and you keep the same number of shares. The company just printed more, and your slice of the bigger pie is now smaller. Use the dilution calculator to model exactly how a round changes your ownership before you sign a term sheet.
What dilutive money buys, and non-dilutive money doesn't, is speed and signal. A seed round closes in 2–8 weeks. A federal grant cycle runs 4–9 months. When a competitor is moving and your window is narrow, the cost of waiting on non-dilutive money can outweigh the cost of equity you give up.
Take dilution when you're buying something other than just cash. The accelerator network. The lead-investor relationship for the next round. The board member who's scaled a similar company. The signal of "Sequoia led our seed" that compresses your customer-acquisition cost. If you're taking equity for cash alone, and the cash could come from non-dilutive sources at a slower pace, you're usually overpaying.
Reach for non-dilutive funding when time-to-cash isn't your binding constraint. R&D-heavy work that the federal government or a foundation already wants to fund. Infrastructure costs that cloud credits cover for free. Revenue-tied financing for a SaaS company with $20K+ MRR that doesn't want to give up equity. The trade-off is real (non-dilutive sources cost 5–15% of grant value in application and reporting overhead), but the dollar-for-dollar cost of capital is far below equity if your company ends up valuable.
The strongest stacks combine 3–5 sources, not 1. A common solo-founder layering through year one and two:
Months 0–3. Cloud credits ($25K–$100K) plus 1–2 small grant applications submitted. Net dilution: 0%.
Months 3–6. Accelerator program plus the accelerator's standard . Net dilution: 7%.
Months 6–12. Top up with a pre-seed SAFE if needed; a grant lands. Net dilution: 12–18%.
Months 12–24. Priced seed round when revenue or pipeline justifies it. Net dilution: 25–35% combined founders' stake. Still well above the "50% through Series A" floor.
The mistake is reaching for the dilutive source first, when the non-dilutive sources are slower but free. Apply early, run multiple in parallel, and let the dilutive round land last when you have the leverage to set terms.
Worth flagging a specific failure mode: many founders stack 3–4 at progressively higher without modeling conversion. Each cap creates a separate price tier; at the priced round, they all convert at once and the founder discovers the cap table is much more diluted than they expected. The math is non-obvious because each tier dilutes the others.
Always model the next two rounds (current SAFEs at their actual caps, plus a 10–15% option-pool top-up) before signing the next SAFE. Lawyers can produce this in an afternoon. Use the dilution calculator for back-of-envelope estimates between meetings.
Debt sits awkwardly on this axis. SBA loans, lines of credit, business credit cards, and revenue-based financing are all non-dilutive (they don't take equity), but they don't behave like grants either. You owe the principal back, with interest, on a defined schedule, no matter how the business is doing. For a company that expects predictable cash flow (a small business, a steady-growth startup), debt is often the cheapest option after grants. For a pre-revenue startup with binary outcomes, debt can sink you faster than an equity dilution would have.
Is my competitive clock ticking? If yes, dilutive money's speed is worth the equity. If no, start with non-dilutive.
What am I actually buying: just cash, or cash plus a relationship? If just cash, every non-dilutive dollar is cheaper. If the relationship is real, dilutive is fair.
Can I support repayment if revenue dips? If yes, debt extends what equity would have to fund. If no, stick to grants, equity, or revenue-share structures.
Founders who optimize for "max cash with min dilution" almost always end up with worse cap tables than those who optimize for "right cash for right milestone." Pace matters more than total raised.